U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 560.300 Reconditioning of Imported, Insect Infested, Insect Damaged or Moldy Coffee Beans
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 560.300 Reconditioning of Imported, Insect Infested, Insect Damaged or Moldy Coffee Beans July 1989

Final

BACKGROUND:

*This policy pertains to the different reconditioning procedures for green coffee beans detained (See Sec. 580.100 for CPG 7103.01) due to the presence of external live and/or dead insect infestation, or detained due to insect damaged and/or moldy coffee beans (See Sec. 510.500 for CPG 7101.06).*

POLICY:

The Food and Drug Administration will continue to detain all actionable lots of green coffee beans offered for entry into the U.S. *Lots detained due to external live insect infestation must be fumigated* in the immediate area of the port to prevent further adulteration of food. After the fumigation has been completed, lots detained due to the presence of *external* live and/or dead insects must be cleaned by sifting and blowing or other suitable means to remove the insects. *The cleaning phase of the reconditioning may be carried out at* the processing facility (roasting plant), if the owner or consignee *requests authorization* and if it has been determined through a current inspection that proper cleaning can be accomplished at the roasting plant.

*Lots* detained due to insect damaged and/or moldy beans *must* be completely reconditioned prior to movement to the processing facility (roasting plant).

*Material between asterisks is new or revised.*

Issued: 10/1/80
Revised: 1/4/82, 7/19/89


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.